This distribution pattern was also found to be significantly different from OC patients with “OC+BC families”, where 29% (8/28; 95% CI 15%‐47%) of mutation carriers was located in the BRCA2 OCCR (P = 0.020; Fisher's test). Here, BRCA2 is linked to breast cancer.